A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

This study has been completed.
Sponsor:
Information provided by:
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00246987
First received: October 28, 2005
Last updated: April 26, 2012
Last verified: April 2012
  Purpose

To determine the effect on glycemic control and lipid parameters of the 2.5 and 5 mg. doses of BMS-298585 in drug naive subjects with Type 2 diabetes as an adjunct to diet and exercise.


Condition Intervention Phase
Diabetes, Type 2
Drug: Muraglitazar
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Resource links provided by NLM:


Further study details as provided by Bristol-Myers Squibb:

Primary Outcome Measures:
  • Change in HbA1c from baseline to Week 24

Secondary Outcome Measures:
  • Changes achieved from baseline in FPG after 24 weeks. Changes achieved from baseline in 3 hour post-prandial AUC for glucose and insulin levels after 24 weeks vs. placebo.

Estimated Enrollment: 341
Study Start Date: June 2003
Study Completion Date: April 2004
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects with Type 2 diabetes
  • Drug Naive
  • HbA1c >= 7.0% and <= 10.0%
  • Body Mass Index <= 41 kg/m2
  • Serum TG <= 600 mg/dL

Exclusion Criteria:

  • Symptomatic Type 2 diabetes
  • History of bladder cancer
  • History of Myocardial Infarction (MI), coronary angioplasty or bypass grafts, valvular disease or repair, unstable angina pectoris, Transient Ischemic Attach (TIA), or Cerebrovascular Accident (CVA) within 6 months, congestive heart failure (NYHA Class II and IV), uncontrolled hypertension, history of renal disease, peripheral vascular disease (PVD), pulmonary disease, gastrointestinal disease, active liver disease or endocrine disease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00246987

  Hide Study Locations
Locations
United States, Alabama
Local Institution
Anniston, Alabama, United States
Local Institution
Birmingham, Alabama, United States
Local Institution
Haleyville, Alabama, United States
Local Institution
Hoover, Alabama, United States
United States, Arizona
Local Institution
Fayetteville, Arizona, United States
Local Institution
Hot Springs, Arizona, United States
Local Institution
Mesa, Arizona, United States
Local Institution
Phoenix, Arizona, United States
Local Institution
Tucson, Arizona, United States
Local Institution
Tulsa, Arizona, United States
United States, California
Local Institution
Concord, California, United States
Local Institution
Fountain Valley, California, United States
Local Institution
Long Beach, California, United States
Local Institution
Los Gatos, California, United States
Local Institution
Raleigh, California, United States
Local Institution
Roseville, California, United States
Local Institution
San Diego, California, United States
Local Institution
Spring Valley, California, United States
Local Institution
Tustin, California, United States
United States, Colorado
Local Institution
Colorado Springs, Colorado, United States
Local Institution
Golden, Colorado, United States
Local Institution
Littleton, Colorado, United States
United States, Connecticut
Local Institution
New Britain, Connecticut, United States
United States, Florida
Local Institution
Altamonte Springs, Florida, United States
Local Institution
Brandon, Florida, United States
Local Institution
Chipley, Florida, United States
Local Institution
Coral Gables, Florida, United States
Local Institution
Kissimmee, Florida, United States
Local Institution
Longwood, Florida, United States
Local Institution
Melbourne, Florida, United States
Local Institution
New Port Richie, Florida, United States
Local Institution
Ocala, Florida, United States
Local Institution
Pinellas Park, Florida, United States
United States, Illinois
Local Institution
Chicago, Illinois, United States
United States, Kansas
Local Institution
Overland Park, Kansas, United States
Local Institution
Shawnee Mission, Kansas, United States
United States, Kentucky
Local Institution
Lexington, Kentucky, United States
Local Institution
Madisonville, Kentucky, United States
United States, Louisiana
Local Institution
Shreveport, Louisiana, United States
United States, Mississippi
Local Institution
Gulfport, Mississippi, United States
Local Institution
St. Peters, Mississippi, United States
United States, Missouri
Local Institution
Chesterfield, Missouri, United States
Local Institution
Kansas City, Missouri, United States
Local Institution
Springfield, Missouri, United States
United States, New Jersey
Local Institution
Elizabeth, New Jersey, United States
Local Institution
Toms River, New Jersey, United States
United States, New York
Local Institution
Endwell, New York, United States
Local Institution
West Seneca, New York, United States
United States, North Carolina
Local Institution
Charlotte, North Carolina, United States
Local Institution
High Point, North Carolina, United States
Local Institution
Morehead City, North Carolina, United States
Local Institution
Salisbury, North Carolina, United States
Local Institution
Winston Salem, North Carolina, United States
United States, Ohio
Local Institution
Franklin, Ohio, United States
Local Institution
Newark, Ohio, United States
Local Institution
Zanesville, Ohio, United States
United States, Oregon
Local Institution
Eugene, Oregon, United States
Local Institution
Portland, Oregon, United States
United States, Pennsylvania
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
Reading, Pennsylvania, United States
Local Institution
Warminster, Pennsylvania, United States
United States, Rhode Island
Local Institution
East Providence, Rhode Island, United States
Local Institution
Johnston, Rhode Island, United States
Local Institution
Providence, Rhode Island, United States
United States, South Carolina
Local Institution
Anderson, South Carolina, United States
Local Institution
Greer, South Carolina, United States
Local Institution
Mount Pleasant, South Carolina, United States
United States, Tennessee
Local Institution
Knoxville, Tennessee, United States
Local Institution
Memphis, Tennessee, United States
United States, Texas
Local Institution
Fort Worth, Texas, United States
Local Institution
Lubbock, Texas, United States
Local Institution
San Angelo, Texas, United States
Local Institution
San Antonio, Texas, United States
United States, Utah
Local Institution
Salt Lake City, Utah, United States
United States, Virginia
Local Institution
Richmond, Virginia, United States
Local Institution
Virginia Beach, Virginia, United States
United States, Washington
Local Institution
Edmonds, Washington, United States
Local Institution
Federal Way, Washington, United States
Local Institution
Olympia, Washington, United States
Local Institution
Spokane, Washington, United States
Local Institution
Vancouver, Washington, United States
United States, Wisconsin
Local Institution
Milwaukee, Wisconsin, United States
Australia, New South Wales
Local Institution
Canberra, New South Wales, Australia
Local Institution
Sydney, New South Wales, Australia
Local Institution
Wollongong, New South Wales, Australia
Australia, Queensland
Local Institution
Kippa Ring, Queensland, Australia
Local Institution
Meadowbrook, Queensland, Australia
Australia, South Australia
Local Institution
Adelaide, South Australia, Australia
Local Institution
Woodville, South Australia, Australia
Australia, Tasmania
Local Institution
Launceston, Tasmania, Australia
Australia, Victoria
Tasmania
Melbourne, Victoria, Australia
Canada, Alberta
Local Institution
Calgary, Alberta, Canada
Local Institution
Edmonton, Alberta, Canada
Canada, British Columbia
Local Institution
Coquitlam, British Columbia, Canada
Canada, Manitoba
Local Institution
Winnipeg, Manitoba, Canada
Canada, Newfoundland and Labrador
Local Institution
Manuels, Newfoundland and Labrador, Canada
Local Institution
St. John's, Newfoundland and Labrador, Canada
Canada, Nova Scotia
Local Institution
Halifax, Nova Scotia, Canada
Canada, Ontario
Local Institution
Markham, Ontario, Canada
Local Institution
Oakville, Ontario, Canada
Local Institution
Ottawa, Ontario, Canada
Local Institution
Thornhill, Ontario, Canada
Local Institution
Thunder Bay, Ontario, Canada
Local Institution
Toronto, Ontario, Canada
Canada, Prince Edward Island
Local Institution
Charlottetown, Prince Edward Island, Canada
Canada, Quebec
Local Institution
Chicoutimi, Quebec, Canada
Local Institution
Drummondville, Quebec, Canada
Local Institution
Granby, Quebec, Canada
Local Institution
Laval, Quebec, Canada
Local Institution
Longueuil, Quebec, Canada
Local Institution
Montreal, Quebec, Canada
Local Institution
Pointe-Claire, Quebec, Canada
Local Institution
St-Lambert, Quebec, Canada
Local Institution
Ste-Foy, Quebec, Canada
Canada, Saskatchewan
Local Institution
Regina, Saskatchewan, Canada
Local Institution
Saskatoon, Saskatchewan, Canada
Mexico
Local Institution
Mexico City, Distrito Federal, Mexico
Local Institution
Cuernavaca, Morelos, Mexico
Local Institution
Aguascalientes, Mexico
Local Institution
Durango, Mexico
Poland
Local Institution
Krakow, Poland
Local Institution
Lodz, Poland
Local Institution
Mrokow, Poland
Local Institution
Warszawa, Poland
Local Institution
Zabrze, Poland
Puerto Rico
Local Institution
Anasco, Puerto Rico
Local Institution
Ponce, Puerto Rico
Local Institution
Rio Pieoras, Puerto Rico
Taiwan
Local Institution
Changhua, Taiwan
Local Institution
Taichung, Taiwan
Sponsors and Collaborators
Bristol-Myers Squibb
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00246987     History of Changes
Other Study ID Numbers: CV168-018
Study First Received: October 28, 2005
Last Updated: April 26, 2012
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 26, 2014